InvestorsHub Logo

uw86

01/13/14 2:06 PM

#248 RE: nbm16yankees #247

first stop I truly believe is around $3.00 per share. cap here is incredibly low at little over $20 million. FDA approval is going to be rapidly discounted in the price of ISR.